Found 14 matching trials
Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica PHASE3 This will be efficacy and safety of Induction and Tapering Therapy with Tof...
Show More Location
Division of Rheumatology, the First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis PHASE4 The aim of this study is to evaluate and compare the efficacy and safety of...
Show More Learn More & Join Trial
Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease. PHASE2 Nowadays, no single drug is approved to treat rheumatoid arthritis-related ...
Show More Location
Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas
Learn More & Join Trial
Determination of the Optimal Treatment Target in Ulcerative Colitis PHASE4 Disease activity and response to therapy in ulcerative colitis (UC) can be ...
Show More Status
Active Not Recruiting
Location
St. Joseph Mercy Hospital/Huron Gastroenterology Associates
Learn More & Join Trial
Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica PHASE2 Glucocorticoids are the cornerstone treatment for polymyalgia rheumatica bu...
Show More Learn More & Join Trial
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis PHASE1 This is a pilot study to determine whether further research is warranted to...
Show More Location
Oregon Health & Science University
Learn More & Join Trial
A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis PHASE4 This study aimed to compare the efficacy and safety of a precision treatmen...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease PHASE4 Pulmonary abnormalities are present in up to 60% of patients with early rhe...
Show More Location
Skåne University Hospital, Department of Rheumatology
Learn More & Join Trial
A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome NA This study is a prospective investigation comparing the efficacy and safety...
Show More Location
China-Japan Friendship Hospital
Learn More & Join Trial
The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients PHASE4 Anti-melanoma differentiation-associated gene5 (Anti-MDA5) antibody positiv...
Show More Location
Department of Rheumatology, the First Affiliated Hospital of Xi'an Jiaotong University
Learn More & Join Trial